NO137135B - RODENTICID AGENTS. - Google Patents
RODENTICID AGENTS. Download PDFInfo
- Publication number
- NO137135B NO137135B NO850/73A NO85073A NO137135B NO 137135 B NO137135 B NO 137135B NO 850/73 A NO850/73 A NO 850/73A NO 85073 A NO85073 A NO 85073A NO 137135 B NO137135 B NO 137135B
- Authority
- NO
- Norway
- Prior art keywords
- calciferol
- warfarin
- bait
- rats
- anticoagulant
- Prior art date
Links
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 claims description 28
- 229960002061 ergocalciferol Drugs 0.000 claims description 28
- MECHNRXZTMCUDQ-RKHKHRCZSA-N ergocalciferol group Chemical group CC(C)[C@@H](C)\C=C\[C@@H](C)[C@H]1CC[C@H]2\C(\CCC[C@]12C)=C\C=C/1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 claims description 28
- 235000001892 vitamin D2 Nutrition 0.000 claims description 28
- 239000011653 vitamin D2 Substances 0.000 claims description 28
- PJVWKTKQMONHTI-UHFFFAOYSA-N warfarin Chemical compound OC=1C2=CC=CC=C2OC(=O)C=1C(CC(=O)C)C1=CC=CC=C1 PJVWKTKQMONHTI-UHFFFAOYSA-N 0.000 claims description 23
- 229960005080 warfarin Drugs 0.000 claims description 21
- 239000003146 anticoagulant agent Substances 0.000 claims description 17
- 229940127219 anticoagulant drug Drugs 0.000 claims description 17
- 230000000694 effects Effects 0.000 claims description 14
- 239000003128 rodenticide Substances 0.000 claims description 13
- 150000001875 compounds Chemical class 0.000 claims description 12
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 9
- 239000003795 chemical substances by application Substances 0.000 claims description 8
- 229930003316 Vitamin D Natural products 0.000 claims description 7
- 235000019166 vitamin D Nutrition 0.000 claims description 7
- 239000011710 vitamin D Substances 0.000 claims description 7
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 7
- 229940046008 vitamin d Drugs 0.000 claims description 7
- 239000012141 concentrate Substances 0.000 claims description 6
- UDHXJZHVNHGCEC-UHFFFAOYSA-N Chlorophacinone Chemical compound C1=CC(Cl)=CC=C1C(C=1C=CC=CC=1)C(=O)C1C(=O)C2=CC=CC=C2C1=O UDHXJZHVNHGCEC-UHFFFAOYSA-N 0.000 claims description 3
- ULSLJYXHZDTLQK-UHFFFAOYSA-N Coumatetralyl Chemical group C1=CC=CC2=C1OC(=O)C(C1C3=CC=CC=C3CCC1)=C2O ULSLJYXHZDTLQK-UHFFFAOYSA-N 0.000 claims description 3
- -1 diphacincne Chemical compound 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims description 2
- 235000005282 vitamin D3 Nutrition 0.000 claims description 2
- 239000011647 vitamin D3 Substances 0.000 claims description 2
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims description 2
- 229940021056 vitamin d3 Drugs 0.000 claims description 2
- HENZOLWOIZODCT-UHFFFAOYSA-N coumachlor Chemical compound OC=1OC2=CC=CC=C2C(=O)C=1C(CC(=O)C)C1=CC=C(Cl)C=C1 HENZOLWOIZODCT-UHFFFAOYSA-N 0.000 claims 1
- 241000700159 Rattus Species 0.000 description 20
- 239000000203 mixture Substances 0.000 description 13
- 241000699670 Mus sp. Species 0.000 description 11
- 238000009472 formulation Methods 0.000 description 8
- 244000075850 Avena orientalis Species 0.000 description 7
- 235000007319 Avena orientalis Nutrition 0.000 description 6
- 235000005687 corn oil Nutrition 0.000 description 6
- 239000002285 corn oil Substances 0.000 description 6
- 241001465754 Metazoa Species 0.000 description 5
- 241000283984 Rodentia Species 0.000 description 4
- 235000013312 flour Nutrition 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- VXIXUWQIVKSKSA-UHFFFAOYSA-N 4-hydroxycoumarin Chemical class C1=CC=CC2=C1OC(=O)C=C2O VXIXUWQIVKSKSA-UHFFFAOYSA-N 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- 230000001747 exhibiting effect Effects 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- 230000001119 rodenticidal effect Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- MJKVTPMWOKAVMS-UHFFFAOYSA-N 3-hydroxy-1-benzopyran-2-one Chemical compound C1=CC=C2OC(=O)C(O)=CC2=C1 MJKVTPMWOKAVMS-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- DEKWZWCFHUABHE-UHFFFAOYSA-N Coumachlor Chemical compound OC=1C2=CC=CC=C2OC(=O)C=1C(CC(=O)C)C1=CC=C(Cl)C=C1 DEKWZWCFHUABHE-UHFFFAOYSA-N 0.000 description 2
- JYGLAHSAISAEAL-UHFFFAOYSA-N Diphenadione Chemical compound O=C1C2=CC=CC=C2C(=O)C1C(=O)C(C=1C=CC=CC=1)C1=CC=CC=C1 JYGLAHSAISAEAL-UHFFFAOYSA-N 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 235000019219 chocolate Nutrition 0.000 description 2
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N coumarin Chemical compound C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 2
- 229960000267 diphenadione Drugs 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 125000005842 heteroatom Chemical group 0.000 description 2
- 239000002480 mineral oil Substances 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 150000003431 steroids Chemical class 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- NDAZXVKUAOEGNN-UHFFFAOYSA-N 3-ethyl-4-hydroxychromen-2-one Chemical compound C1=CC=C2OC(=O)C(CC)=C(O)C2=C1 NDAZXVKUAOEGNN-UHFFFAOYSA-N 0.000 description 1
- WFFZGYRTVIPBFN-UHFFFAOYSA-N 3h-indene-1,2-dione Chemical class C1=CC=C2C(=O)C(=O)CC2=C1 WFFZGYRTVIPBFN-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 240000002470 Amphicarpaea bracteata Species 0.000 description 1
- 235000007558 Avena sp Nutrition 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 235000019733 Fish meal Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229960000956 coumarin Drugs 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000008029 eradication Effects 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000004467 fishmeal Substances 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 231100000225 lethality Toxicity 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- 125000004430 oxygen atom Chemical group O* 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
Landscapes
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Toxicology (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Agronomy & Crop Science (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Description
Nærværende oppfinnelse vedrorer rodenticide sammensetninger. Oppfinnelsen fremskaffer en sammensetning som består av: The present invention relates to rodenticidal compositions. The invention provides a composition consisting of:
a) et antikoagulant rodenticid, og a) an anticoagulant rodenticide, and
b) en forbindelse som oppviser vitamin D-aktivitet. b) a compound exhibiting vitamin D activity.
Vektforholdet mellom konponent a) og komponent b) er fra The weight ratio between component a) and component b) is from
99 : 1 til 1 : 99, fortrinnsvis fra 80 : 20 til 10 : 90. 99:1 to 1:99, preferably from 80:20 to 10:90.
'Warfariri' ( 3( a-f enyl-(3-acetyl) -ety1-4-hydroksy kumar in) og 'Warfariri' (3(α-phenyl-(3-acetyl)-ethyl-4-hydroxy coumarin) and
andre antikoagulant-forbindelser anvendes nesten bestandig for regulering av rotte.- og andre gnager-populas joner og har en kumulativ toksisitet ved at rotter og mus drepes med en dose other anticoagulant compounds are almost always used to control rat and other rodent populations and have a cumulative toxicity in that rats and mice are killed with one dose
i storr elsesordenen 1 mg/kg, og som gis i form av lokkemat i en tidsperiode på 4 - 5 dager. Noen rotter og mus har imidlertid utviklet en motstand overfor antikoagulanter, og vil nå tåle meget hoyerer mengdenivåer enn de som normalt skal til for å avlive dyrene. in the order of 1 mg/kg, and which is given in the form of bait for a period of 4 - 5 days. However, some rats and mice have developed a resistance to anticoagulants, and will now tolerate much higher levels than those normally required to euthanize the animals.
Det er også kjent at forbindelser, som oppviser vitamin D-aktivitet, som f.eks. "Calciferol", er toksiske overfor rotter og mus ved administrasjon over flere dager, idet en av døds-årsakene er absorpsjon av kalsium fra knokler som avsettes i nyrene. Imidlertid er "Calciferol" selv ikke egnet som et rodenticid p.g.a. at mengdenivåene, ved hvilke det må anvendes, gjor anvendelsen for kostbar, og p.g.a. den langsomme avliv-ningen ved anvendelse av okonomiske konsentrasjoner. It is also known that compounds which exhibit vitamin D activity, such as e.g. "Calciferol", are toxic to rats and mice when administered over several days, as one of the causes of death is absorption of calcium from bones which is deposited in the kidneys. However, "Calciferol" itself is not suitable as a rodenticide due to that the quantity levels at which it must be used make the application too expensive, and because the slow killing when using economic concentrations.
Nærværende oppfinnelse har sitt utspring i at det er funnet The present invention has its origin in the discovery
at blandinger av antikoagulant-rodenticider med forbindelser som oppviser vitamin D-aktivitet, har en toksisk effekt på gnagere som er storre enn summen av toksisiteten til de to forbindelsene. Det er overraskende at forbindelser med vitamin D-aktivitet er i stand til å forsterke toksisiteten av antikoagulant-forbindelser,' og da ikke bare når det gjelder normale rotter og mus, men også rotter og mus som er motstandsdyktige overfor antikoagulant-forbindelsene som sådanne. Sammensetningene ifolge nærværende oppfinnelse er effektive gifter for flere skadedyr, spesielt gnagere såsom rotter og mus. that mixtures of anticoagulant rodenticides with compounds exhibiting vitamin D activity have a toxic effect on rodents greater than the sum of the toxicity of the two compounds. It is surprising that compounds with vitamin D activity are able to enhance the toxicity of anticoagulant compounds, not only in normal rats and mice, but also in rats and mice resistant to the anticoagulant compounds as such. The compositions according to the present invention are effective poisons for several pests, especially rodents such as rats and mice.
Antikoagulant-rodenticidene er generelt stoffer som i og for seg er kjente. Den viktigste klassen er derivater av 4-hydroksy-kumarin. Disse derivater omfatter 3,3'-metylen - The anticoagulant rodenticides are generally substances that are known per se. The most important class is derivatives of 4-hydroxy-coumarin. These derivatives include 3,3'-methylene -
bis (4-hydroksy-kumarin), kumatetralyl £4-hydroksy-3-(1,2,3,4-tetrahydronaf tyl) kumarin ^ 3( a-f enyl-(3-acetyl) ety 1-4-hydroksy-kumarin og 3(a-heteromonocyklisk P-acyl)-etyl-4-hydroksy-kumariner. Acylgruppen i de to sistnevnte typene rodenticider er fortrinnsvis en acetylgruppe. Feny1-gruppen i a-stillingen kan være substituert og da spesielt ved et halogenatom eller en nitrogruppe. Heteromonocyklen kan inneholde ett eller flere oksygenatomer som heteroatom eller heteroatomer. Eksempler på slike forbindelser er 3-( a-paraklor of enyl-|3 -acetyl) -ety 1-4- bis (4-hydroxy-coumarin), coumatetralyl £4-hydroxy-3-(1,2,3,4-tetrahydronaphthyl)coumarin ^ 3( α-phenyl-(3-acetyl)ethyl 1-4-hydroxy-coumarin and 3(α-heteromonocyclic β-acyl)-ethyl-4-hydroxy-coumarins. The acyl group in the latter two types of rodenticides is preferably an acetyl group. The phenyl group in the α-position can be substituted and then especially by a halogen atom or a nitro group. The heteromonocycle can contain one or more oxygen atoms as a heteroatom or heteroatoms. Examples of such compounds are 3-( a-parachloro of enyl-|3 -acetyl)-ethy 1-4-
hydroksykumarin, 3-(a-f enyl-|3-acetyl)-etyl-4-hydroksykumarin og 3[a-(2'-furyl)-P-acetyl] etyl-4-hydroksykumarin. Man kan også anvende aryl- og acylsubstituerte indan-dioner, såsom de som inneholder en fenyl- eller substituert fenylgruppe og bis-metyl-propiolyl-deri vater , f.eks. 2 ,.2-bis (metylpropolyl) - indan-1,3-dion. Blandt kommersielt tilgjengelige antikoagulant-rodenticider har man de som er kjent gjennom I.S.O. Særlig in-teressante er midler ifolge foreliggende oppfinnelse som inneholder "Warfarin" (eller kumafen eller zookumarin), "Cou-metetralyl", "Diphacinone", "Chlorphacinone" og "Coumachlor", henholdsvis de vi.tamin-D-aktive komponentene ergocalciferol og cholecalciferol. Sistnevnte er derivater av 3[3-hydroksy-^ 5 7_ 17(3-substituerte steroider, hvor typen 17(3-substituent ikke er kritisk, og erholdes generelt fra steroider, såsom ergosterol, ved bestrålning. hydroxycoumarin, 3-(α-phenyl-|3-acetyl)-ethyl-4-hydroxycoumarin and 3[α-(2'-furyl)-β-acetyl] ethyl-4-hydroxycoumarin. Aryl- and acyl-substituted indanediones can also be used, such as those containing a phenyl or substituted phenyl group and bis-methyl-propiolyl derivatives, e.g. 2,.2-bis(methylpropolyl)-indan-1,3-dione. Among the commercially available anticoagulant rodenticides are those known through I.S.O. Particularly interesting are agents according to the present invention which contain "Warfarin" (or coumafen or zoocoumarin), "Cou-metetralyl", "Diphacinone", "Chlorphacinone" and "Coumachlor", respectively the vitamin D-active components ergocalciferol and cholecalciferol. The latter are derivatives of 3[3-hydroxy-^ 5 7_ 17(3-substituted steroids, where the type of 17(3-substituent is not critical, and are generally obtained from steroids, such as ergosterol, by irradiation.
Midlene ifolge nærværende oppfinnelse kan foreligge i The agents according to the present invention can be present in
form av en rodenticid-formulering, f.eks. som lokkemat eller som et konsentrat for utspedning ved anvendelse. Rodenticide formuleringer kan hensiktsmessig inneholde fra 0,005 til 0,5 vektsprosent antikoagulant-rodenticid og fra 0,005 til 0,5 vektsprosent av en forbindelse som oppviser vitamin D-aktivitet. Beskaffenheten til resten i slike rodenticide formuleringer er ikke kritisk ifolge oppfinnelsen. form of a rodenticide formulation, e.g. as bait or as a concentrate for dilution in application. Rodenticidal formulations may suitably contain from 0.005 to 0.5 weight percent anticoagulant rodenticide and from 0.005 to 0.5 weight percent of a compound exhibiting vitamin D activity. The nature of the residue in such rodenticidal formulations is not critical according to the invention.
Lokkemat er gjerne basert på fast korn-mat, f.eks. Bait food is often based on solid grain food, e.g.
havre, havremel, maismel, hvetemel og kornstivelse og fiske-mel. Sukker er nyttig som et tilsetningsstoff til annen lokkemat, og sjokolade er en attraktiv lokkemat. Sjokolade kan anvendes alene eller sammen med annen lokkemat. Vegetabilske , animalske eller mineral-oljer, som f.eks. jordnottolje, kornolje eller mineralolje kan anvendes alene eller som tilsetnings-stoffer til annen lokkemat. oats, oat flour, corn flour, wheat flour and corn starch and fish meal. Sugar is useful as an additive to other baits, and chocolate is an attractive bait. Chocolate can be used alone or together with other baits. Vegetable, animal or mineral oils, such as e.g. peanut oil, corn oil or mineral oil can be used alone or as additives to other baits.
Man kan også tilsette fargestoff til formuleringen for å advare og unngå forveksling. Fargestofftypen er ikke kritisk, Dye can also be added to the formulation to warn and avoid confusion. The type of dye is not critical,
men man foretrekker en blå eller rod farge. Et antioksydasjons-middel kan anvendes, og typen er heller ikke kritisk. but a blue or red color is preferred. An antioxidant can be used, and the type is not critical either.
Midlet kan fremstilles som et konsentrat i en inert The agent can be prepared as a concentrate in an inert
substans, f.eks. pulverformig kritt eller aluminiumoksyd, for utspedning med en egnet spiselig, substans som rottene liker. Alternativt kan midlet opploses i en olje, f.eks. kornolje, substance, e.g. powdered chalk or aluminum oxide, for dilution with a suitable edible substance that the rats like. Alternatively, the agent can be dissolved in an oil, e.g. corn oil,
for blanding med lokkemat-utspedningsmidlet. Konsentratet inneholder gjerne fra 0,1 til 10 vektsprosent av hver av komponentene a) og b). for mixing with the bait diluent. The concentrate usually contains from 0.1 to 10% by weight of each of the components a) and b).
Et eksempel på en formulering er en blanding av 97,5% kritt-pulver, 0,5% "Warfarin" og 2,0% "Calciferol" som ved utspedning med 19 deler havre gir en lokkemat som inneholder 0,025% "Warfarin" og 0,1% "Calciferol". An example of a formulation is a mixture of 97.5% chalk powder, 0.5% "Warfarin" and 2.0% "Calciferol" which when diluted with 19 parts of oats gives a bait containing 0.025% "Warfarin" and 0.1% "Calciferol".
Et eksempel på det sistnevnte er en opplosning av 0,5% "Warfarin" og 2% "Calciferol i kornolje eller et annet egnet medium. En •lokkemat kan fremstilles ved å blande en del av opplosningen med 19 deler havre. An example of the latter is a solution of 0.5% "Warfarin" and 2% "Calciferol" in corn oil or another suitable medium. A bait can be prepared by mixing one part of the solution with 19 parts of oats.
Folgende eksempler illustrerer oppfinnelsen, delene er gitt i vektsdeler. Eksempel 1 til 4 er rodenticide formuleringer som er klare for bruk. The following examples illustrate the invention, the parts are given in parts by weight. Examples 1 to 4 are ready-to-use rodenticide formulations.
EKSEMPEL 1 EXAMPLE 1
EKSEMPEL 2 EXAMPLE 2
EKSEMPEL 3 EKSEMPEL 4 EXAMPLE 3 EXAMPLE 4
Eksemplene 5 til 7 er konsentrater som er ment for utspedning med 19 vektdeler av et akseptabelt basismateriale hos brukeren. Examples 5 to 7 are concentrates intended for dilution with 19 parts by weight of a base material acceptable to the user.
EKSEMPEL 5 EXAMPLE 5
EKSEMPEL 6 EXAMPLE 6
0,5% "Warfarin i 99,5% fint havregryn 0.5% "Warfarin in 99.5% fine oatmeal
2,0% "Calciferol i 98,0% kornolje. 2.0% "Calciferol in 98.0% corn oil.
EKSEMPEL 7 EXAMPLE 7
EKSEMPEL 8 EXAMPLE 8
Den forsterkende effekten av et middel vises i tabell.1, The reinforcing effect of a drug is shown in table.1,
idet en lokkemat som inneholdt 0,025% "Warfarin" og/eller 0,01% "Calciferol" ble gitt til "Warfarin"-motstandsdyktige rotter i flere dager, og hvorved "Warfarin" og "Calciferol" wherein a bait containing 0.025% "Warfarin" and/or 0.01% "Calciferol" was given to "Warfarin" resistant rats for several days, whereby "Warfarin" and "Calciferol"
ble administrert i en lokkemat som bestod av vanlig havre. was administered in a bait consisting of plain oats.
Man ser at "Warfarin"alene har en meget liten effekt på disse motstandsdyktige rottene. "Calciferol" alene gir på det meste 33% dodlighet, mens "Warfarin" og "Calciferol" sammen gir 50% dodlighet på ca. 3,5 dager og 100% dodlighet på noe over 8 dager. It can be seen that "Warfarin" has very little effect on these resistant rats. "Calciferol" alone gives at most 33% mortality, while "Warfarin" and "Calciferol" together give 50% mortality of approx. 3.5 days and 100% mortality in anything over 8 days.
EKSEMPEL 9 EXAMPLE 9
Det ble fremstilt lokkemat med formuleringene som gjengis i nedenstående tabell 2 ved at man dispergerte en aceton-slurry med de aktive ingrediensene i vanlig havregryn og tor-ket produktet i 24 timer. Innestengte dyr ble kontinuer- Baits were prepared with the formulations shown in Table 2 below by dispersing an acetone slurry with the active ingredients in ordinary oatmeal and drying the product for 24 hours. Confined animals were continuously
lig utsatt for lokkemat, og i lopet av matningsperioden fikk body exposed to bait, and in the course of the feeding period got
dyrene ikke noen alternativ fode. Ubegrensede mengder av led-ningsvann var tilgjengelig. Lokkematen ble erstattet hver dag og resten veid for å bestemme den fortærte mengden. Antallet av forsoksdyr som dode hver dag ble notert. Ovrige detaljer angis i nedenstående tabell 2. the animals no alternative fodder. Unlimited amounts of tap water were available. The bait was replaced each day and the remainder weighed to determine the amount consumed. The number of experimental animals that died each day was noted. Other details are given in table 2 below.
Ikke i noe tilfelle ble alle resistente gnagere drept In no case were all resistant rodents killed
ved hjelp av antikoagulant alene. using anticoagulant alone.
"Calciferol" alene har alltid gitt dodelighet, men ved "Calciferol" alone has always given lethality, but by
samme konsentrasjoner ble avlivningshastigheten og prosenten dode dyr alltid storre når "Calciferol" ble administrert sammen med en antikoagulant. same concentrations, the killing rate and the percentage of dead animals were always greater when "Calciferol" was administered together with an anticoagulant.
F.eks. når det gjelder resistente mus: E.g. in the case of resistant mice:
1. 0,025% "Warfarin" drepte ingen mus i lopet av en 56 dagers administrasjonsperiode. 1. 0.025% "Warfarin" did not kill any mice over a 56 day administration period.
2. 0,005% "Calciferol" drepte alle mus, men forst eftér 2. 0.005% "Calciferol" killed all mice, but only after
29 dagers administrasjon. Musene dode mellom den 16. og 29. dagen. 29 day administration. The mice died between the 16th and 29th day.
3. 0,005% "Calciferol" + 0,025% "Warfarin" administrert i 3. 0.005% "Calciferol" + 0.025% "Warfarin" administered in
12 dager drepte alle resistente mus mellom 4. og 12. dagen. 12 days killed all resistant mice between days 4 and 12.
Eksempel med resistente rotter: Example with resistant rats:
1. 0,025% "Warfarin" drepte bare en rotte i lopet av en 10 dagers administrasjonsperiode. 0,025% "Coumatetralyl", "Diphacinone", "Chlorophacinone" og "Coumaklor" drepte hhv. 3/5, 1/5, 2/5 og 0/5 i lopet av en 10 dagers periode. Alle anti-koagulanter, som ble provet i kombinasjon med "Calciferol, drepte alle provede rotter i lopet av 10 dager. 2. 0,025% "Warfarin" + 0,01% "Calciferol" drepte 12/12 av de resistente rotter innen 10 dager. De to stoffene som ble provet hver for seg ved samme konsentrasjoner drepte bare 1/9 og 3/9 av rottene på.. 10 dager. 3. 0,025%"Calciferol"administrert alene i 10 dager, drepte 10/12 av de resistente rotter mellom 3. og 8. 1. 0.025% "Warfarin" killed only one rat over a 10 day administration period. 0.025% "Coumatetralyl", "Diphacinone", "Chlorophacinone" and "Coumachlor" killed respectively. 3/5, 1/5, 2/5 and 0/5 over the course of a 10 day period. All anticoagulants tested in combination with "Calciferol" killed all tested rats within 10 days. 2. 0.025% "Warfarin" + 0.01% "Calciferol" killed 12/12 of the resistant rats within 10 days . The two substances tested separately at the same concentrations killed only 1/9 and 3/9 of the rats in .. 10 days. 3. 0.025% "Calciferol" administered alone for 10 days killed 10/12 of the resistant ones rats between 3. and 8.
dagen. 0,025% "Calciferol" + 0,025% "Warfarin", som ble administrert bare i 4 dager, drepte 14/14 av rottene mellom 3. og 6. dagen. the day. 0.025% "Calciferol" + 0.025% "Warfarin", which was administered only for 4 days, killed 14/14 of the rats between the 3rd and 6th day.
EKSEMPEL 10 EXAMPLE 10
Dette eksempel viser virkningen ved feltforsok hvorved man tilsatte"Warfarin" til en "Calciferol"-holdig lokkemat. This example shows the effect of a field experiment whereby "Warfarin" was added to a "Calciferol"-containing bait.
Man fremstilte lokkemat ved å tilberede en oljelosning av "Calciferol", blande denne med pulverformig "Warfarin"-konsentrat i det tilfelle "Warfarin" ble anvendt, og så utspe med havremel. Baits were prepared by preparing an oil solution of "Calciferol", mixing this with powdered "Warfarin" concentrate in the case that "Warfarin" was used, and then adding oatmeal.
Forsoks-lokkemat med bare havregryn ble lagt omkring hver gård for å bestemme de best beliggende lokkemat-stedene. Trial baits containing only oat groats were placed around each farm to determine the best-situated bait sites.
Forsoks-lokkemat ble plassert i vanlige, kommersielt tilgjengelige lokkemat-kar, idet hvert kar inneholdt over-skudd av lokkemat som var bestemt ved de innledende forsok. Trial baits were placed in common, commercially available bait tubs, each tub containing a surplus of bait as determined in the initial trials.
Lokkematen ble undersokt på de angitte dagene. Når tydelige tegn på rotte-aktivitet kunne iakttas anmerket man dette med "tatt". Lokkematen ble oppsamlet og veiet for å bestemme den konsumerte lokkemat-mengden. Frisk lokkemat ble lagt ut ved hvert forsok. The bait was examined on the indicated days. When clear signs of rat activity could be observed, this was marked with "taken". The bait was collected and weighed to determine the amount of bait consumed. Fresh bait was placed at each trial.
Resultatene vises i nedenstående tabeller III og IV. The results are shown in Tables III and IV below.
Vurdering av forsokene: Assessment of the trials:
(i) Når 0,10%"Calciferol" ble anvendt alene så har det åpenbart vært en reduksjon i aktiviteten, og efter 23 dagers kontinuerlig lokkemating kunne man fremdeles observere et visst forbruk som indikerte ufullstendig utrydning. (ii) Ved anvendelse av 0,10% "Calciferol" + 0,025% "Warfarin" ble aktiviteten redusert meget hurtigere, og man kunne ikke oppdage levende rotter efter 9 dager. (i) When 0.10% "Calciferol" was used alone, there was obviously a reduction in activity, and after 23 days of continuous bait feeding, some consumption could still be observed, indicating incomplete eradication. (ii) When using 0.10% "Calciferol" + 0.025% "Warfarin" the activity was reduced much faster, and no live rats could be detected after 9 days.
Det bor legges merke til at de sistnevnte resultatene ble oppnådd på gårder som var plaget av rotter som var bevist å være antikoagulant-resistente. It should be noted that the latter results were obtained on farms infested with rats proven to be anticoagulant resistant.
Feltforsokdata: Field trial data:
i) Effekten av "Calciferol" uten anitkoagulant. Farm A, Lancashire. i) The effect of "Calciferol" without anticoagulant. Farm A, Lancashire.
Mindre rotteangrep rundt uthus. Less rat infestation around outbuildings.
Formulering Formulation
0,10% "Calciferol" 0.10% "Calciferol"
5,00% kornolje 5.00% corn oil
94.90% knappenålshode-havremel.. 94.90% pinhead oatmeal..
ii) Effekten av"Calciferol"med antikoagulant. Farm B, Merioneth. ii) The effect of "Calciferol" with anticoagulant. Farm B, Merioneth.
Resistente rotter. Standard-laboratorie-forsok bekreftet resistens hos 9/10 av rottene fanget på stedet. Resistant rats. Standard laboratory tests confirmed resistance in 9/10 of the rats caught at the site.
Formulering Formulation
0,100% "Calciferol" 0.100% "Calciferol"
0,025% "Warfarin" 0.025% "Warfarin"
5,000% kornolje 5,000% corn oil
94.875% mellomfint havremel. 94.875% medium fine oat flour.
Claims (5)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1015572A GB1371135A (en) | 1972-03-03 | 1972-03-03 | Rodenticidal compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO137135B true NO137135B (en) | 1977-10-03 |
| NO137135C NO137135C (en) | 1978-01-11 |
Family
ID=9962550
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO850/73A NO137135C (en) | 1972-03-03 | 1973-03-02 | RODENTICID AGENTS. |
Country Status (11)
| Country | Link |
|---|---|
| BE (1) | BE796208A (en) |
| CA (1) | CA999235A (en) |
| CH (1) | CH577786A5 (en) |
| DK (1) | DK136881B (en) |
| FR (1) | FR2174878B1 (en) |
| GB (1) | GB1371135A (en) |
| IT (1) | IT983472B (en) |
| NL (1) | NL175021C (en) |
| NO (1) | NO137135C (en) |
| SE (1) | SE398812B (en) |
| ZA (1) | ZA731165B (en) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4868206A (en) * | 1985-12-06 | 1989-09-19 | Ici Americas Inc. | Composition for rodent control |
| CA1326813C (en) * | 1989-05-17 | 1994-02-08 | Hector F. De Luca | Method of exterminating rodents and other vertebrate pests |
| WO2000002447A1 (en) * | 1998-07-08 | 2000-01-20 | Kiwicare Corporation Limited | Pesticide in gel form |
| DE10001801A1 (en) * | 2000-01-18 | 2001-07-19 | Bayer Ag | New synergistic combination of an anticoagulant and unicellular parasite sporocysts, e.g., warfarin and Sarcocystis singaporensis sporocysts, is useful in killing rodents |
| DE10023401A1 (en) * | 2000-05-12 | 2001-11-15 | Bayer Ag | Rodenticidal composition containing sporocysts of pathogenic protozoa in water-containing gel, optionally together with bait, retains water content and infectious activity on prolonged storage |
| RU2011119138A (en) * | 2008-10-14 | 2012-11-27 | Байер Кропсайенс Аг | SYNERGETIC RODENTICIDE |
| CA2987439C (en) * | 2015-02-10 | 2023-07-04 | Bayer Cropscience Aktiengesellschaft | Use of an agent to control resistant rodents |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1350900A (en) * | 1970-09-17 | 1974-04-24 | Ici Ltd | Rodenticides |
-
1972
- 1972-03-03 GB GB1015572A patent/GB1371135A/en not_active Expired
-
1973
- 1973-02-19 ZA ZA731165A patent/ZA731165B/en unknown
- 1973-02-22 IT IT20718/73A patent/IT983472B/en active
- 1973-02-26 CA CA164,576A patent/CA999235A/en not_active Expired
- 1973-03-01 FR FR7307254A patent/FR2174878B1/fr not_active Expired
- 1973-03-01 SE SE7302930A patent/SE398812B/en unknown
- 1973-03-02 DK DK115673AA patent/DK136881B/en unknown
- 1973-03-02 NO NO850/73A patent/NO137135C/en unknown
- 1973-03-02 BE BE128313A patent/BE796208A/en not_active IP Right Cessation
- 1973-03-05 NL NLAANVRAGE7303068,A patent/NL175021C/en not_active IP Right Cessation
- 1973-03-05 CH CH319573A patent/CH577786A5/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| BE796208A (en) | 1973-09-03 |
| NL7303068A (en) | 1973-09-06 |
| NL175021B (en) | 1984-04-16 |
| IT983472B (en) | 1974-10-31 |
| NL175021C (en) | 1984-09-17 |
| DE2310636B2 (en) | 1976-01-15 |
| FR2174878A1 (en) | 1973-10-19 |
| CA999235A (en) | 1976-11-02 |
| DK136881B (en) | 1977-12-12 |
| DE2310636A1 (en) | 1973-09-20 |
| GB1371135A (en) | 1974-10-23 |
| SE398812B (en) | 1978-01-23 |
| ZA731165B (en) | 1973-11-28 |
| FR2174878B1 (en) | 1978-06-23 |
| CH577786A5 (en) | 1976-07-30 |
| NO137135C (en) | 1978-01-11 |
| DK136881C (en) | 1978-05-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT2090164E (en) | A rodenticide bait based on a synergetic association of anticoagulant active ingredients | |
| CN105050408B (en) | Kill the soft bait composition of rodent | |
| US2687365A (en) | Warfarin rodenticide bait composition and process of making same | |
| CN102349513A (en) | Biological insecticide containing methoprene as well as preparation and application methods thereof | |
| NO137135B (en) | RODENTICID AGENTS. | |
| Mercer et al. | Mechanisms of toxicity and residue considerations of rodenticide exposure in food Animals—a FARAD perspective | |
| US4011332A (en) | Hemorrhagic-lesion producing and anticoagulant-containing compositions and their use | |
| US4156714A (en) | Rodenticidal compositions | |
| US3113071A (en) | Rodenticide food bait containing anticoagulant and antibacterial agents | |
| CA2323433A1 (en) | Enhancing the toxicity of warfarin in rodents | |
| US7709530B2 (en) | Rodenticidal composition in the form of vegetable paste | |
| GB2329125A (en) | Warfarin compositions | |
| SU1344228A3 (en) | Rodenticide composition | |
| US2872367A (en) | Insecticidal compositions containing 9,9'-bifluorylidene | |
| US4021568A (en) | Rodenticidal compositions containing 2-chloro-3-phytyl-1,4-naphthaquinone and warfarin | |
| EP3295793B1 (en) | Environmentally compatible degradable rodenticide formulations | |
| US3260645A (en) | Rodenticide comprising 3-[1'-(p-chlorophenyl)-propyl]-4-hydroxycoumarin and beta-diethylaminoethyl diphenylpropylacetate | |
| RU2201676C2 (en) | Rodenticide preparation | |
| CA1066619A (en) | Rodenticide | |
| DE2310636C3 (en) | Rodenticides means | |
| RU2285404C2 (en) | Rodenticide composition | |
| CN102415391B (en) | Emamectin benzoate-RH-5849 compounded pesticide preparation and preparation method thereof | |
| US3629469A (en) | Method for controlling birds | |
| Tretiakov et al. | Influence of preparative form on the target efficiency and toxicity of the solid insecticide based on pyrethroid and neonicatinoid | |
| US3185622A (en) | Rodenticide bait composition with monosodium glutamate |